OncLive: Dr. Mesa on mitigating racial disparities in MPN clinical trials

Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses mitigating racial disparities in myeloproliferative neoplasm (MPN) clinical trials.

Watch the interview.



Share This Article!